254 completed, 47 unknown, 36 terminated, 17 withdrawn. 170 Phase 2, 83 Phase 1, 69 Phase 4, 68 Phase 3, 23 Not applicable.
Follow Placebo Oral Capsule: new trials by email Literature Review of Placebo Oral Capsule trials Research Report on Placebo Oral Capsule
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Research Investigating Drug Effects-2 (RiDE-2) Placebo Oral Capsule, THC - Cannabis Use, Substance Use Disorder (SUD) | Early Phase 1 | Not yet recruiting | University of Illinois at Chicago | 144 | 2027-01-04 | 2026-10-22 |
| A Phase 1/2a Study of Oral PRO-1562 in Healthy Subjects and Patients With Relapsing Multiple Sclerosis PRO-1562 Oral Capsules, Placebo Oral Capsule - Multiple Sclerosis | Phase 1 / Phase 2 | Recruiting | Progentos Therapeutics | 160 | 2026-10-01 | 2026-09-29 |
| Short-term Effects of Methamphetamine on Residual Latent HIV Disease Study Oral Methamphetamine, Placebo oral capsule - HIV -1 Infection, Methamphetamine Use | Phase 4 | Not yet recruiting | University of California, San Francisco | 20 | 2026-10-01 | 2026-08-17 |
| Bi-level Erector Spinae Plane Block and Pre-emptive Oral Tizanidine for Analgesia After Mastectomy Surgery Bilevel erector spinae plane block, Placebo Oral Capsule, tizanidine oral capsule - Mastectomy Patient | Not applicable | Completed | Mansoura University | 90 | 2025-07-15 | 2026-01-27 |
| Enhancing Recovery Through a Combined Mechanobiologic Intervention Following Meniscus Repair Fisetin, Placebo oral capsule - Meniscus Tear, Meniscus; Derangement | Phase 2 / Phase 3 | Withdrawn | Austin V Stone | 2025-07-01 | 2025-05-08 | |
| Efficacy of Pregabalin for Diabetic Pruritus - A Randomized Controlled Study. Pregabalin 75 mg, Placebo Oral Capsule - Diabetic Pruritus, Efficacy of Pregabalin in Controlling Diabetic Pruritus Severity | Phase 4 | Recruiting | Post Graduate Institute of Medical Education and Research, Chandigarh | 46 | 2025-04-17 | 2026-01-05 |
| Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-reactivity Cytisinicline, Placebo Oral Capsule - Smoking Cessation, Tobacco Use Disorder | Phase 2 | Recruiting | University of California, Los Angeles | 64 | 2024-12-05 | 2025-12-03 |
| Evaluation of Fertitonex Effects on Semen Parameters in Clinical Varicocele Patient. Fertitonex capsule, Placebo Oral Capsule - Varicocele | Not applicable | Recruiting | Menoufia University | 110 | 2024-12-01 | 2025-03-26 |
| Citicoline in Youth Alcohol Use Disorder Citicoline (cytidine diphosphate-choline), Placebo oral capsule - Alcohol Use Disorder | Phase 2 | Active not recruiting | Medical University of South Carolina | 56 | 2024-10-01 | 2026-06-12 |
| Evaluation of the Efficacy and Safety of Stiripentol in Patients 6 Years and Older With Primary Hyperoxaluria Type 1, 2 or 3 Stiripentol Oral Capsule, Placebo Oral Capsule, Urine samples collect - Primary Hyperoxaluria Type 1, Primary Hyperoxaluria Type 2 | Phase 3 | Not yet recruiting | Biocodex | 42 | 2024-08-01 | 2024-06-18 |
| Efficacy of Valbenazine for the Treatment of Trichotillomania in Adults Valbenazine Oral Capsule, Placebo Oral capsule - Trichotillomania (Hair-Pulling Disorder) | Phase 2 | Recruiting | Yale University | 20 | 2024-02-02 | 2026-02-03 |
| Voclosporin in Adolescent and Pediatric Subjects With Lupus Nephritis Voclosporin, Placebo Oral Capsule - Adolescent Lupus Nephritis, Pediatric Lupus Nephritis | Phase 3 | Terminated | Aurinia Pharmaceuticals Inc. | 9 | 2023-10-10 | 2026-02-10 |
| Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz) Pazopanib, Placebo oral capsule - Hereditary Hemorrhagic Telangiectasia, Epistaxis | Phase 2 / Phase 3 | Active not recruiting | Cure HHT | 70 | 2023-05-08 | 2026-03-19 |
| GetHealthy-OA: A Program to Improve Pain and Function for Patients With Knee Osteoarthritis, Obesity, and Depression Fisetin, GetHealthy-OA mind-body program, Placebo oral capsule - Knee Osteoarthritis, Obese | Phase 2 / Phase 3 | Withdrawn | Cale Andrew Jacobs, PhD | 2023-04-01 | 2023-05-01 | |
| Effect of Basis™ and High Intensity Interval Training (HIIT) on Muscle Metabolism and Exercise Performance NRPT, Placebo oral capsule - Healthy | Phase 1 | Withdrawn | Elysium Health | 2023-02-01 | 2023-02-15 | |
| Acetazolamide on REM OSA Placebo oral capsule, Acetazolamide - Obstructive Sleep Apnea | Phase 1 / Phase 2 | Completed | Brigham and Women's Hospital | 11 | 2023-01-30 | 2026-01-20 |
| Phase II Trial of Fecal Microbiota Transplant (FMT) for VRE and CRE Patients FMT Capsule DE, Placebo oral capsule - Clostridium Difficile Infection | Phase 2 | Withdrawn | University of Wisconsin, Madison | 2022-09-01 | 2021-02-23 | |
| Treatment Effects of Bisoprolol and Verapamil in Symptomatic Patients With Non-obstructive Hypertrophic Cardiomyopathy Verapamil, Bisoprolol, Placebo - Non-obstructive Hypertrophic Cardiomyopathy | Phase 4 | Recruiting | Morten Steen Kvistholm Jensen | 100 | 2022-08-10 | 2025-03-20 |
| Pirfenidone Treat Myocardial Fibrosis After Acute Myocardial Infarction Pirfenidone Oral Capsule, Placebo Oral Capsule - Myocardial Fibrosis | Phase 2 | Unknown | Shanghai Zhongshan Hospital | 100 | 2022-08-05 | 2022-11-10 |
| Evaluation of the Immunopharmacology of EDP1815 and EDP2939 EDP1815, EDP2939, Placebo oral capsule - KLH and Imiquimod Induced Skin Inflammation in Healthy Volunteers | Phase 1 | Completed | Evelo Biosciences, Inc. | 38 | 2022-06-27 | 2023-05-19 |
Showing 20 of 379. Sign in to see all of them.
Inflammation (14) · Heart Failure (11) · Pulmonary Disease, Chronic Obstructive (10) · Sleep Apnea, Obstructive (10) · Altitude Sickness (9) · Parkinson Disease (9) · Alcoholism (8) · Cognitive Dysfunction (7) · Marijuana Abuse (7) · Alzheimer Disease (6) · Colitis, Ulcerative (6) · Diabetes Mellitus, Type 2 (6) · Obesity (6) · Depression (5) · Emphysema (5)
University of Zurich (18) · Brigham and Women's Hospital (8) · Johns Hopkins University (7) · Mayo Clinic (5) · Medical University of South Carolina (5) · Universitas Indonesia (5) · University of California, San Francisco (5) · Yale University (5) · Biogen (4) · Neurocrine Biosciences (4) · Aelis Farma (3) · Aptinyx (3) · Aurinia Pharmaceuticals Inc. (3) · Evelo Biosciences, Inc. (3) · Indiana University (3)
United States (181) · United Kingdom (30) · Canada (24) · Australia (18) · Kyrgyzstan (16) · Spain (16) · Germany (14) · Netherlands (13) · France (12) · Switzerland (9) · China (8) · Denmark (8) · Belgium (7) · Brazil (7) · Poland (7)
Konrad E Bloch, MD (14) · Talant M Sooronbaev, MD (13) · Michael Furian, MSc (8) · Silvia Ulrich, MD (6) · Ekaterina Zakharova, MD, PhD (3) · Duncan McHale, MD, PhD (2) · Fernando L Pagan, MD (2) · Hugh Brent Solvason (2) · Jan LS Thomsen, MD (2) · Kevin M Gray, MD (2) · Michael Risbano, MD, MA (2) · Nancy J Brown, MD (2) · Robert Wise, MD (2)
PMID 36326435, PMID 36408587, PMID 37291212, PMID 38296630, PMID 10990106, PMID 11486303, PMID 1298430, PMID 15371767, PMID 15915023, PMID 16106006, PMID 16225607, PMID 16792648, PMID 17513656, PMID 17656479, PMID 18331513, PMID 18670407, PMID 18716003, PMID 18724858, PMID 19056618, PMID 19538334, PMID 19751895, PMID 19919979, PMID 19920054, PMID 19965540, PMID 20089497, PMID 20507380, PMID 20887423, PMID 21157303, PMID 21204265, PMID 21673295, PMID 21771755, PMID 21782228, PMID 21943027, PMID 22087680, PMID 22153774, PMID 22638939, PMID 22653877, PMID 22741619, PMID 22822075, PMID 22824930, PMID 22892729, PMID 23097067, PMID 23254903, PMID 23291734, PMID 23293330, PMID 23391319, PMID 23598691, PMID 23666528, PMID 23876346, PMID 24408869
2017 (14), 2016 (7), 2018 (4), 2015 (2), R01DA038875 (2), 1UG3AR077748-01 (1), 1UH2NS094258-01 (1), 2019 (1), 2023 (1), K23AA025399 (1), K23DA048132 (1), P01HL103455 (1), P50DA009236 (1), R01AA026190 (1), R01AG013241 (1)